SARFEZ Trademark

Trademark Overview

On Monday, July 31, 2017, a trademark application was filed for SARFEZ with the United States Patent and Trademark Office. The USPTO has given the SARFEZ trademark a serial number of 87549883. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Wednesday, May 29, 2024. This trademark is owned by Sarfez Pharmaceuticals Inc. The SARFEZ trademark is filed in the Pharmaceutical Products category with the following description:

Cardiorenal medication
sarfez

General Information

Serial Number87549883
Word MarkSARFEZ
Filing DateMonday, July 31, 2017
Status701 - SECTION 8 - ACCEPTED
Status DateWednesday, May 29, 2024
Registration Number5644543
Registration DateTuesday, January 1, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2018

Trademark Statements

Goods and ServicesCardiorenal medication

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 3, 2017
Primary Code005
First Use Anywhere DateThursday, June 1, 2006
First Use In Commerce DateThursday, June 1, 2006

Trademark Owner History

Party NameSarfez Pharmaceuticals Inc
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressVienna, VA 22182
Party NameSarfez Pharmaceuticals Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressVienna, VA 22182
Party NameSarfez Pharmaceuticals Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVienna, VA 22182

Trademark Events

Event DateEvent Description
Thursday, November 2, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 3, 2017NEW APPLICATION ENTERED
Thursday, August 3, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 31, 2017ASSIGNED TO EXAMINER
Thursday, November 2, 2017NON-FINAL ACTION WRITTEN
Thursday, November 2, 2017NON-FINAL ACTION E-MAILED
Thursday, January 4, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 21, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, December 3, 2017ASSIGNED TO LIE
Tuesday, December 5, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 5, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 20, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 20, 2017REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Wednesday, December 20, 2017NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Wednesday, December 20, 2017NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Thursday, January 4, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 14, 2018SU - NON-FINAL ACTION - WRITTEN
Tuesday, January 9, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 31, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 20, 2018PUBLISHED FOR OPPOSITION
Tuesday, February 20, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 17, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 14, 2018TEAS STATEMENT OF USE RECEIVED
Friday, September 14, 2018USE AMENDMENT FILED
Wednesday, October 10, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 10, 2018STATEMENT OF USE PROCESSING COMPLETE
Monday, January 22, 2024TEAS SECTION 8 RECEIVED
Tuesday, May 28, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, May 29, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED
Wednesday, May 29, 2024NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Monday, January 1, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, November 14, 2018NON-FINAL ACTION E-MAILED
Wednesday, November 14, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 29, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, November 30, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 1, 2019REGISTERED-PRINCIPAL REGISTER

Related Keywords

sarfez medication cardiorenal